The proliferation of substandard medicines represents a deeply concerning problem facing the global healthcare landscape. These fraudulent products, often mimicking legitimate medications, pose a significant danger to individual safety, undermining therapy effectiveness and potentially leading to severe harmful health outcomes. Motivated by substan